Alan
Alan Agrees €480M Series G Led by Prosus
Alan announced €480M in Series G financing on June 25, 2026. Alan agreed a €480 million Series G led by Prosus at a €5.5 billion valuation to expand into new countries and invest in AI and healthcare services.
Round details
The financing includes backing from Prosus, Teachers’ Venture Growth, Index Ventures, Dara Holdings. The company reported a €5.5B valuation alongside the transaction.
- Round: Series G
- Capital announced: €480M
How the company plans to use the capital
Alan said it plans to expand into several new countries, deepen its presence in France, Belgium, Spain and Canada, pursue acquisitions, and keep investing heavily in artificial intelligence, healthcare services and product innovation. Closing of the round is subject to regulatory approvals, including from the relevant French financial authorities.
Why this matters for GTM teams
Prosus described healthcare as one of the most significant global opportunities for AI-led transformation, and Alan listed international expansion and continued investment in AI among its plans for the new funds.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Alan Series G announcement.
Company Info
Investors (4)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


